Literature DB >> 21753259

A large outbreak of influenza B-associated benign acute childhood myositis in Germany, 2007/2008.

Sabine Mall1, Udo Buchholz, Daniel Tibussek, Annette Jurke, Matthias An der Heiden, Sabine Diedrich, Brunhilde Schweiger, Katharina Alpers.   

Abstract

BACKGROUND: Benign acute childhood myositis (BACM) is a rare syndrome associated with various viral infections. Bilateral calve pain may lead to inability to walk. During winter 2007/2008, we investigated a nationwide outbreak of influenza-associated BACM (IA-BACM) to identify etiologic (sub)type, describe the course of disease, and explore how well the syndrome is known among physicians.
METHODS: We performed retrospective and prospective case finding in all German federal states. Physicians returned patient-based questionnaires containing information about sex, age, disease progression, patient-management, and number of BACM cases treated previously. We compared IA-BACM cases with influenza cases from the German virologic sentinel surveillance system for influenza.
RESULTS: We investigated 219 children with IA-BACM. They coincided with the curve of influenza B of the German virologic sentinel surveillance system for influenza. Median age was 7 years, 74% (160/216) of cases were male, median time between the onset of fever and onset of BACM-symptoms was 3 days lasting for a median of 4 days. Almost half of the affected children had presented at hospitals. One case with beginning renal impairment occurred, but the patient recovered completely. Most reporting physicians had not seen BACM-patients previously. Multivariable analysis showed IA-BACM's strong association with influenza B, male sex, and age between 6 and 9 years.
CONCLUSIONS: Influenza B caused a large BACM outbreak in Germany. Onset of BACM symptoms followed shortly after the onset of influenza symptoms. The course of this disease was almost exclusively mild and self-limiting. Diagnosis of this rare but distinct clinical entity by the alert physician can spare the patient potentially unneeded invasive testing and hospital admission.

Entities:  

Mesh:

Year:  2011        PMID: 21753259     DOI: 10.1097/INF.0b013e318217e356

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Simple diagnosis of benign acute childhood myositis: Lessons from a case report.

Authors:  Vito Terlizzi; Federica Improta; Valeria Raia
Journal:  J Pediatr Neurosci       Date:  2014 Sep-Dec

2.  Benign acute childhood myositis complicating influenza B infection in a boy with idiopathic nephrotic syndrome.

Authors:  Piotr Skrzypczyk; Joanna Przychodzień; Małgorzata Pańczyk-Tomaszewska
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085

3.  Coexistence of myositis, transverse myelitis, and Guillain Barré syndrome following Mycoplasma pneumoniae infection in an adolescent.

Authors:  Yasemin Topcu; Erhan Bayram; Pakize Karaoglu; Uluc Yis; Handan Guleryuz; Semra Hiz Kurul
Journal:  J Pediatr Neurosci       Date:  2013-01

4.  Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses.

Authors:  Marion Desdouits; Sandie Munier; Marie-Christine Prevost; Patricia Jeannin; Gillian Butler-Browne; Simona Ozden; Antoine Gessain; Sylvie Van Der Werf; Nadia Naffakh; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

5.  A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.

Authors:  Chantelle L White; Kevin Chiem; Daniel R Perez; Jefferson Santos; Stivalis Cardenas Garcia; Aitor Nogales; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2021-06-30       Impact factor: 5.048

6.  Impact of A/H1N1 influenza in children at a Brazilian University Hospital.

Authors:  Gabriela Fontanella Biondo; João Carlos Santana; Patrícia M Lago; Jefferson Piva; Paulo Ricardo A Souza; Joana Genz Gaulke; Juliana M Sebben
Journal:  Braz J Infect Dis       Date:  2018-06-05       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.